Pharmaceuticals (Basel, Switzerland)

Improving Weight Loss with GLP-1 Treatments by Keeping Muscle Strength and Metabolism Healthy Using Personalized Nutrition and Strength Training

Updated

Abstract

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) enable significant non-surgical weight loss that may improve metabolic health.

  • Total body weight does not differentiate between fat loss and loss of skeletal muscle mass, which is crucial for overall health.
  • A multidimensional framework of high-quality weight loss focuses on reducing body fat while preserving muscle mass and function.
  • Older adults, individuals with sarcopenic obesity, and those with type 2 diabetes may be at higher risk for negative outcomes from lean tissue loss.
  • Nutritional strategies such as precision protein intake and dietary fiber adequacy could mitigate the adverse effects of weight loss on muscle mass.
  • Resistance training is highlighted as an essential exercise strategy for maintaining lean mass and physical function during weight loss.
  • Monitoring body composition and providing integrated multidisciplinary care are critical for achieving sustainable and clinically favorable weight loss.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

The authors declare no conflicts of interest.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free